Richard Chesworth, Chief Scientific Officer at Kymera Therapeutics, Inc. (KYMR), sold 67,558 shares at $60.12 ($4.1M) on 2021-08-27, disclosed to the SEC on 2021-08-27.
Open-market sale of $4.1M KYMR by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.12 | 33,779 | $2.0M | 50.0% |
| 2 | $60.12 | 33,779 | $2.0M | 50.0% |
| Total | $60.12 avg | 67,558 | $4.1M | 100% |